JP2023552790A5 - - Google Patents
Info
- Publication number
- JP2023552790A5 JP2023552790A5 JP2023534646A JP2023534646A JP2023552790A5 JP 2023552790 A5 JP2023552790 A5 JP 2023552790A5 JP 2023534646 A JP2023534646 A JP 2023534646A JP 2023534646 A JP2023534646 A JP 2023534646A JP 2023552790 A5 JP2023552790 A5 JP 2023552790A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyldiyl
- peg
- alkyl
- immunoconjugate according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124396P | 2020-12-11 | 2020-12-11 | |
| US63/124,396 | 2020-12-11 | ||
| PCT/US2021/062824 WO2022125908A1 (en) | 2020-12-11 | 2021-12-10 | Anti-pd-l1 immunoconjugates, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552790A JP2023552790A (ja) | 2023-12-19 |
| JP2023552790A5 true JP2023552790A5 (cg-RX-API-DMAC7.html) | 2024-12-11 |
Family
ID=79288110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534646A Pending JP2023552790A (ja) | 2020-12-11 | 2021-12-10 | 抗pd-l1イムノコンジュゲート、及びそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240033370A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4259209A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552790A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230118149A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116723866A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021398552A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3200168A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303491A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022125908A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3200056A1 (en) | 2020-12-11 | 2022-06-16 | Shelley Erin ACKERMAN | Anti-her2 immunoconjugates, and uses thereof |
| US20250000995A1 (en) * | 2021-10-29 | 2025-01-02 | Bolt Biotherapeutics, Inc. | Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof |
| WO2024173387A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| AU5345901A (en) | 2000-04-13 | 2001-10-30 | Univ Rockefeller | Enhancement of antibody-mediated immune responses |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| US20070014795A1 (en) | 2004-12-30 | 2007-01-18 | Dhodapkar Madhav V | Compositions and methods for enhanced dendritic cell maturation and function |
| AU2006312148B2 (en) | 2005-11-07 | 2012-04-12 | The Rockefeller University | Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| PE20090245A1 (es) | 2007-05-08 | 2009-03-17 | Genentech Inc | Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos |
| BRPI0818780A2 (pt) | 2007-10-19 | 2015-04-22 | Genentech Inc | Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos |
| EP2640727B1 (en) | 2010-11-17 | 2015-05-13 | Genentech, Inc. | Alaninyl maytansinol antibody conjugates |
| HRP20210977T1 (hr) | 2014-02-10 | 2021-09-17 | Merck Patent Gmbh | Ciljano inhibiranje tgf beta |
| JP6805142B2 (ja) | 2014-11-21 | 2020-12-23 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | Cd73に対する抗体およびその使用 |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| RS63116B1 (sr) * | 2016-05-06 | 2022-05-31 | Shanghai De Novo Pharmatech Co Ltd | Derivat benzazepina, postupak za dobijanje, farmaceutska kompozicija i njegova upotreba |
| CA3049791A1 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| AU2018236272B2 (en) * | 2017-03-15 | 2022-03-31 | Silverback Therapeutics, Inc. | Benzazepine compounds, conjugates, and uses thereof |
| SG11202101980VA (en) * | 2018-09-12 | 2021-03-30 | Silverback Therapeutics Inc | Methods and composition for the treatment of disease with immune stimulatory conjugates |
| JP2022537158A (ja) * | 2019-06-13 | 2022-08-24 | ボルト バイオセラピューティクス、インコーポレーテッド | アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用 |
| EP3983080A1 (en) * | 2019-06-13 | 2022-04-20 | Bolt Biotherapeutics, Inc. | Macromolecule-supported aminobenzazepine compounds |
| CA3176626A1 (en) * | 2020-05-08 | 2021-11-11 | David Dornan | Elastase-substrate, peptide linker immunoconjugates, and uses thereof |
| US20220195066A1 (en) * | 2020-12-11 | 2022-06-23 | Bolt Biotherapeutics, Inc. | Anti-cea immunoconjugates, and uses thereof |
-
2021
- 2021-12-10 JP JP2023534646A patent/JP2023552790A/ja active Pending
- 2021-12-10 KR KR1020237022941A patent/KR20230118149A/ko active Pending
- 2021-12-10 AU AU2021398552A patent/AU2021398552A1/en active Pending
- 2021-12-10 CN CN202180080177.5A patent/CN116723866A/zh active Pending
- 2021-12-10 WO PCT/US2021/062824 patent/WO2022125908A1/en not_active Ceased
- 2021-12-10 CA CA3200168A patent/CA3200168A1/en active Pending
- 2021-12-10 IL IL303491A patent/IL303491A/en unknown
- 2021-12-10 EP EP21840291.5A patent/EP4259209A1/en active Pending
- 2021-12-10 US US18/038,910 patent/US20240033370A1/en active Pending